Rubella Susceptibility in Multiparous Women
NCT00401505 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 310
Last updated 2019-02-22
Summary
The purpose of this study is to determine the reasons why multiparous women (women who are pregnant and have been pregnant before) might still be susceptible to rubella.
Conditions
- Rubella
- Vaccine
Sponsors & Collaborators
-
Unity Health Toronto
lead OTHER
Principal Investigators
-
Mark H Yudin, MD, MSc · Unity Health Toronto
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-09-30
- Primary Completion
- 2012-09-30
- Completion
- 2012-09-30
Countries
- Canada
Study Locations
More Related Trials
-
Study Comparing a DTaP-HB-PRP~T Combined Vaccine With Tritanrix HepB/Hib™, Concomitantly With OPV in Healthy Infants
NCT00348881 ·Status: COMPLETED ·Phase: PHASE3
-
Immune Memory Foll Pry Vaccination With DTPw-HBV/Hib Vaccine Formulation; Immuno & Reacto of Booster Dose at 15-18 Mths
NCT00158808 ·Status: COMPLETED ·Phase: PHASE2
-
Pertussis (Tdap) Vaccination in Pregnancy
NCT01698346 ·Status: COMPLETED ·Phase: PHASE4
-
Vaccination In Pregnancy Gene Signature: VIP Signature Study
NCT03284515 ·Status: COMPLETED
-
Study of Immunogenicity and Safety of a Booster Dose of DTaP-IPV-HB-PRP~T Combined Vaccine in Healthy Turkish Infants
NCT00619502 ·Status: COMPLETED ·Phase: PHASE3
-
Optimising the Timing of Whooping Cough Immunisation in MUMs
NCT03908164 ·Status: UNKNOWN ·Phase: PHASE4
-
The Long-term Antibody Persistence of GSK Biologicals' Meningococcal Vaccine GSK134612 in Healthy Toddlers
NCT00718666 ·Status: COMPLETED ·Phase: PHASE2
-
Maternal Determinants of Infant Immunity to Pertussis
NCT05856396 ·Status: COMPLETED ·Phase: PHASE4
-
Study of a Booster Dose of Hib-MenC Conjugate Vaccine vs Infanrix Hexa When Given to 14 Month Old Subjects
NCT00323050 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants
NCT05065177 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children
NCT00311441 ·Status: COMPLETED ·Phase: PHASE4
-
Coadministration of Measles-rubella and Rotavirus Vaccines
NCT01700621 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine in Healthy Non-pregnant Females From 9 to 49 Years of Age
NCT05169905 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB PRP~T Combined Vaccine in Filipino Infants
NCT00514709 ·Status: COMPLETED ·Phase: PHASE3
-
Assess Feasibility of an Acellular Pertussis Vaccine (Pa) Given Soon After Birth, Followed by 3-dose Primary Vaccination With the DTPa-HBV-IPV/Hib Vaccine
NCT00289796 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years Old
NCT01249183 ·Status: COMPLETED ·Phase: PHASE3
-
To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines
NCT00140686 ·Status: COMPLETED ·Phase: PHASE3
-
Optimising Protection for Pregnant Women and Infants With Maternal Vaccination
NCT03457194 ·Status: ACTIVE_NOT_RECRUITING
-
Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately
NCT01457508 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability of the Japanese Encephalitis Vaccine IC51
NCT00605085 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of a Refrigerator-stable Formulation of VARIVAX®
NCT00432731 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hib™, Both Given Concomitantly With Oral Polio Vaccine
NCT00343889 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults
NCT00311493 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™
NCT01358825 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers
NCT04535037 ·Status: COMPLETED ·Phase: PHASE4